Back to VRDN
MORGAN STANLEY VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
29
Latest value
$2.8M
Q2 2026
Peak value
$46.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $436K |
| Q3 2025 | $390K |
| Q3 2025 | $34K |
| Q3 2025 | $1.8M |
| Q3 2025 | $1.4M |
| Q3 2025 | $43 |
| Q3 2025 | $104K |
| Q4 2025 | $674K |
| Q4 2025 | $2K |
| Q4 2025 | $81K |
| Q4 2025 | $46.7M |
| Q4 2025 | $3.8M |
| Q4 2025 | $60 |
| Q4 2025 | $50K |
| Q4 2025 | $2.8M |
| Q1 2026 | $587K |
| Q1 2026 | $67K |
| Q1 2026 | $13.1M |
| Q1 2026 | $638K |
| Q1 2026 | $40 |
| Q1 2026 | $2K |
| Q1 2026 | $2.7M |
| Q2 2026 | $839K |
| Q2 2026 | $79K |
| Q2 2026 | $8.8M |
| Q2 2026 | $830K |
| Q2 2026 | $30 |
| Q2 2026 | $29K |
| Q2 2026 | $2.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $2.8M | 151.3K | — | — |
| Q2 2026 | $29K | 1.6K | — | — |
| Q2 2026 | $30 | 1 | — | — |
| Q2 2026 | $830K | 45.2K | — | — |
| Q2 2026 | $8.8M | 480.8K | — | — |
| Q2 2026 | $79K | 4.3K | — | — |
| Q2 2026 | $839K | 45.7K | — | — |
| Q1 2026 | $2.7M | 135.8K | — | — |
| Q1 2026 | $2K | 99 | — | — |
| Q1 2026 | $40 | 2 | — | — |
| Q1 2026 | $638K | 32.6K | — | — |
| Q1 2026 | $13.1M | 668.2K | — | — |
| Q1 2026 | $67K | 3.4K | — | — |
| Q1 2026 | $587K | 30.0K | — | — |
| Q4 2025 | $2.8M | 91.0K | — | — |
| Q4 2025 | $50K | 1.6K | — | — |
| Q4 2025 | $60 | 1 | — | — |
| Q4 2025 | $3.8M | 121.0K | — | — |
| Q4 2025 | $46.7M | 1.50M | — | — |
| Q4 2025 | $81K | 2.6K | — | — |
| Q4 2025 | $2K | 78 | — | — |
| Q4 2025 | $674K | 21.6K | — | — |
| Q3 2025 | $104K | 4.8K | — | — |
| Q3 2025 | $43 | 2 | — | — |
| Q3 2025 | $1.4M | 63.5K | — | — |
| Q3 2025 | $1.8M | 83.7K | — | — |
| Q3 2025 | $34K | 1.6K | — | — |
| Q3 2025 | $390K | 18.1K | — | — |
| Q3 2025 | $436K | 20.2K | — | — |